Michelle Mattson is an individual investor and Related Person at Keystone Private Income Fund, located in Salt Lake City. See sector focus.
Michelle Mattson is an individual investor and Related Person at Keystone Private Income Fund, located in Salt Lake City. Mattson is involved with iNFixion Bioscience, a drug discovery company dedicated to developing treatments for Neurofibromatosis Type 1 (NF1). The company's core mission is to enhance the quality of life for individuals affected by NF1. iNFixion Bioscience achieves this by focusing on addressing the fundamental cause of the condition, which stems from a specific mutation within the NF1 gene.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Salt Lake City when building a target list.
Investors like Michelle Mattson · Full investor directory · Investor access · Company funding database